Alessandra Vignola is President of the Cardiovascular & Metabolic business unit at Worldwide Clinical Trials. She has more than 30 years of pharmaceutical and clinical research experience, with therapeutic expertise across indications including cardiovascular, endocrinology, gastrointestinal, liver, immunology, hematology, and oncology. From project management and strategic planning to clinical operations and business strategy, she brings a wealth of expertise to her work at Worldwide.
Alessandra began her career as a Clinical Research Associate at Bristol Myers Squibb, followed by various roles at Pfizer, PPD, and Thermo Fisher Scientific — most recently as a Vice President, Metabolic & Liver Disease Area Lead. She holds a BS in Pharmacy Biochemistry from the Universidade de São Paulo and is fluent in English, Portuguese, and Spanish.
To conduct meaningful research, we must be sure to view these studies through patients’ eyes. The patient perspective — in all its diversity — must be embedded into clinical trials from the very start.